Becton DickinsonBDX +2.44%76 FCF Margin % is 10.08% as of Mar. 2026, which is 30% below its 10-year median of 14.34. GuruFocus rates BDX with a GF Score™ of 76/100 and a GF Value™ of $191.05 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Becton Dickinson ranks better than 83.44% on this metric.
The historical rank and industry rank for Becton Dickinson's FCF Margin % or its related term are showing as below:
BDX'
s FCF Margin % Range Over the Past 10 Years
Min: 8.8 Med: 14.34 Max: 18.05
Current: 14.31
During the past 13 years, the highest FCF Margin % of Becton Dickinson was 18.05%. The lowest was 8.80%. And the median was 14.34%.
BDX's FCF Margin % is ranked better than 83.44% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.1
vs BDX: 14.31
Becton Dickinson FCF Margin % Related Terms
Becton Dickinson FCF Margin % Historical Data
* Premium members only.
The historical data trend for Becton Dickinson's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Becton Dickinson's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Becton Dickinson FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Becton Dickinson's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Becton Dickinson's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Becton Dickinson (BDX) has a FCF Margin % of 10.08% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Becton Dickinson and its competitors. This is 30% below median its historical median of 14.34. Over the past decade, Becton Dickinson's FCF Margin % has ranged from 8.80 to 18.05. According to the industry distribution chart, Becton Dickinson ranks #135 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 16.6%.
Is Becton Dickinson's FCF Margin % too high?
Becton Dickinson's current FCF Margin % of 10.08% is 30% below median its 10-year median of 14.34. Over the past 10 years, this metric has ranged from a low of 8.80 to a high of 18.05. Based on the distribution chart, Becton Dickinson ranks #135 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Becton Dickinson has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Becton Dickinson's FCF Margin % compare to MDLN and RMD?
According to the Medical Devices & Instruments industry distribution chart, Becton Dickinson ranks #135 out of 815 companies for FCF Margin %. This places Becton Dickinson in the top 17% of its industry — outperforming the majority of peers. Historically, Becton Dickinson's own FCF Margin % has ranged from 8.80 to 18.05 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Becton Dickinson and its competitors. Becton Dickinson's current FCF Margin % is 10.08%, which is 30% below median its own 10-year median of 14.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Becton Dickinson stock overvalued right now?
Based on GuruFocus' analysis, Becton Dickinson (BDX) is currently considered Modestly Undervalued. The stock's GF Value™ is $191.05, compared to a current price of $151.38 — trading 20.8% below its estimated fair value. The current FCF Margin % is 10.08%, which is 30% below median its 10-year median of 14.34. Becton Dickinson's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Becton Dickinson (BDX), the current FCF Margin % is 10.08% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Becton Dickinson (BDX) Overvalued in 2026?
Based on GuruFocus' analysis, Becton Dickinson stock appears to be undervalued.
The current stock price of $151.38 is trading 20.8% below its estimated GF Value™ of $191.05.
GuruFocus considers Becton Dickinson to be Modestly Undervalued.
Key valuation signals for BDX:
FCF Margin %: 10.08% (30% below median its 10-year median of 14.34)
GF Value™: $191.05 vs. price of $151.38 (20.8% below fair value)
No single metric tells the full story. See the BDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
76GF Score
Get the complete analysis for BDX
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BDX has been successfully added to your 
